SNDX SYNDAX PHARMACEUTICALS INC Management Changes 8-K Filing 2023 - Appointment and Resignation Syndax Pharmaceuticals announced the appointment of Neil Gallagher as President, Head of Research and Development, and the resignation of Briggs Morrison from the same position.Get access to all SEC 8-K filings of the SYNDAX PHARMACEUTICALS INC